Atlas Trials

Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients

Clinical trial NCT01872897 · COMPLETED

Trial details

NCT number
NCT01872897
Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2013-07-02
Primary completion
2013-12-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.